Vikram Kashyap, MD
Specialty: Vascular Surgery
- Co-Director, Harrington Heart and Vascular Institute, University Hospitals
- Division Chief, Vascular Surgery, UH Cleveland Medical Center
- Professor, CWRU School of Medicine
Vikram Kashyap, MD, FACS, is a board-certified vascular surgeon at University Hospitals Cleveland Medical Center where he serves as Chief of the Division of Vascular Surgery and Endovascular Therapy. He is also Co-Director of the Vascular Center within the UH Harrington Heart & Vascular Institute, the appointed Alan H. Markowitz MD Endowed Chair in Cardiovascular Surgery and a professor of surgery at Case Western Reserve University School of Medicine. Dr. Kashyap has led the Vascular Center since 2011 and trains both residents and fellows in complex vascular procedures. His special clinical interests include endovascular therapies, cerebrovascular disease, aortic pathologies and atherosclerotic occlusive disease.
Dr. Kashyap completed his undergraduate work at Pennsylvania State University, earning a Bachelor of Science with High Distinction and received his medical degree from the Jefferson Medical College in Philadelphia, PA in a combined six-year program. He was inducted into the Alpha Omega Alpha Medical Honor Society and, upon graduation, he received the William F. Kellow Prize for “exemplifying the attributes of an ideal physician.”
After completing his internship and residency in surgery at Massachusetts General Hospital, Harvard Medical School in Boston, MA, Dr. Kashyap was selected for a research fellowship at the National Heart, Lung and Blood Institute in Bethesda, MD to study atherogenesis. After that, he went on to complete a vascular and endovascular surgery fellowship at the University of California, Los Angeles. Dr. Kashyap was Chief of Vascular Surgery at Wilford Hall Medical Center at Lackland Air Force Base, Texas from 1999 – 2003. He was commissioned as an officer in the US Air Force and rose to the rank of Lt. Col. He was attached to the White House Medical Unit and provided medical support for overseas trips by President Clinton. Dr. Kashyap was then on the staff of the Cleveland Clinic from 2003 – 2011 before joining University Hospitals.
Dr. Kashyap’s research interests are atherosclerosis, thrombosis and cerebrovascular disease. He is Principal Investigator on a study of endothelial function in peripheral arteries and several clinical studies of new vascular stents, grafts and prostheses. He leads a national trial on trans-carotid artery revascularization, is widely published in peer-reviewed medical journals and has authored or co-authored more than 200 articles and book chapters.
Dr. Kashyap is a fellow of the American College of Surgeons and a distinguished fellow of the Society for Vascular Surgery. He is a past president of the Vascular and Endovascular Surgery Society (formerly Peripheral Vascular Surgery Society) and past president of the Cleveland Vascular Society. Other professional society affiliations include the American Surgical Association and the Society for Clinical Vascular Surgery.
Dr. Kashyap is listed in the Guide to America’s Top Surgeons and has been named one of Cleveland’s Top Doctors for nearly a decade. He was in the inaugural Leadership Academy sponsored by University Hospitals and Case Western Reserve University Weatherhead School of Management.
In his free time, he enjoys tennis and competed in the 2010 USTA National Championships with Cleveland Racquet Club’s Men’s Team.
- Aortic Pathologies
- Cerebrovascular Disease
- Endovascular Therapies
- Peripheral Occlusive Disease
- Surgical Revascularization
- Vascular Surgery - American Board of Surgery
Fellowship | Vascular Surgery
Vascular Surgery - University Of California, Los Angeles David Geffen School Of Medicine (1997 - 1999)
Research Fellowship | General Surgery
General Surgery - National Institutes Of Health (1993 - 1995)
Residency | General Surgery
General Surgery - Massachusetts General Hospital (1990 - 1997)
Jefferson Medical College Of Thomas Jefferson University (1990)
Pennsylvania State University (1986)
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Vikram Kashyap did not disclose any Outside Relationships with Industry.